Search results
FDA Approves New Bladder Cancer Drug
Medscape· 4 days agoThe first-in-class agent is approved alongside bacillus Calmette-Guérin to treat certain non–muscle-invasive bladder cancers that do not respond to...
NHS trials first personal skin cancer jab that can halve risk of death
The Telegraph via Yahoo News· 14 hours agoIain Foulkes, the executive director of research and innovation at Cancer Research UK, said:...
Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Zacks via Yahoo Finance· 5 hours agoApproval of better HIV treatments should strengthen the HIV franchise in the wake of the increasing...
'I would look pregnant': When is bloating the sign of something more serious? An expert weighs in
Yahoo Canada Style· 3 hours agoThe bloating was constant and…it felt like really intense menstrual crampsAlvina Nadeem Alvina...
US FDA approves ImmunityBio's bladder cancer therapy - BusinessWorld Online
BusinessWorld· 4 days agoThe US health regulator approved on Monday ImmunityBio’s combination therapy to treat a type of ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 2 days agoFurther, the companies are running a late-stage study in non-small cell lung cancer patients. One...
Recurrence Data for Narrow Band Imaging™ (NBI™) Technology Show Value in the Fight Against...
WSYR 9 Syracuse· 2 days ago"Without dyes, without any change to the patient's standard cystoscopy, and with only a push of a button, urologists can better visualize a lesion, and potentially contribute to reduced recurrence ...
U.K. Tests World-First Personalized Skin Cancer Vaccine
Forbes· 15 hours agoPersonalized with genetic information from a patient’s own tumor, vaccines like this could one day...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Yucaipa News Mirror· 2 days agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced colorectal cancer: Safety and efficacy results from a phase ...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 2 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...
